US Gov't Plans To Control COVID Vaccine Distribution At Least Through 2022; Already Authorized Products Have Booster Advantage

Due to need to plan for potential vaccine boosters now, administration is focusing on contracting with the companies whose shots are already being given in the US, David Kessler tells the Senate health committee. Data on whether it is ok to ‘mix and match’ vaccine types with boosters should be available in a few months.

David Kessler testifies at 11 May Senate HELP hearing on COVID-19
David Kessler, HHS Chief Science Officer for COVID, testifies 11 May at the Senate HELP Committee • Source: Screenshot

More from Vaccines

More from Pink Sheet